Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma: A case series and review of literature

Sarbani Ghosh-Laskar, Jai Prakash Agarwal, Prahlad H. Yathiraj, Prasad Tanawade, Rajendra Panday, Tejpal Gupta, Ashwini Budrukkar, Vedang Murthy

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Background: Brain metastasis from primary head and neck squamous cell carcinoma (HNSCC) is infrequent and probably under-reported thereby leading to paucity of information. Methods: Archives of two institutes in India were studied from 2005 to 2013 and relevant information regarding patient demographics, treatment details, and follow-up was obtained for patients having brain metastasis (BM) from HNSCC. Data were analyzed using SPSS software version 20 (IBM Corporation, NY, USA). Results: Metastasis to the brain was detected in 17 patients with an HNSCC primary. The median age for diagnosis of index primary was 55 years (range (R) - 32-71 years) with 88% (15/17) being male. Oral cavity was the most common site of primary disease with 35% (6/17) followed by larynx (24%), oropharynx (18%), and hypopharynx (18%). The median stage at presentation was IVA (47%) and two (12%) were metastatic to the brain at presentation. Human papillomavirus analysis was not available for any of the patients. Neurological symptoms were complained of in 94% patients. The median BM-free-interval was 15 months (R - 1-67 months, SE ± 5.2). While 88% had multiple brain metastases, 82% also had extracranial metastasis and in 53% of patients, the index primary was not controlled. The median overall survival of all patients after the development of BM was 2 months (R - 0.5-6 months, SE ± 0.4). Conclusion: BM in HNSCC is mostly multiple, associated with extracranial metastasis and can occur in patients without locoregional relapse or residual disease and carries a dismal outcome.

Original languageEnglish
Pages (from-to)1160-1163
Number of pages4
JournalJournal of Cancer Research and Therapeutics
Volume12
Issue number3
DOIs
Publication statusPublished - 01-07-2016

Fingerprint

Neoplasm Metastasis
Brain
Carcinoma, squamous cell of head and neck
Hypopharynx
Oropharynx
Larynx
Mouth
India
Software
Demography
Recurrence
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Ghosh-Laskar, Sarbani ; Agarwal, Jai Prakash ; Yathiraj, Prahlad H. ; Tanawade, Prasad ; Panday, Rajendra ; Gupta, Tejpal ; Budrukkar, Ashwini ; Murthy, Vedang. / Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma : A case series and review of literature. In: Journal of Cancer Research and Therapeutics. 2016 ; Vol. 12, No. 3. pp. 1160-1163.
@article{5686d4d2ce204bde9bac69091d3e6575,
title = "Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma: A case series and review of literature",
abstract = "Background: Brain metastasis from primary head and neck squamous cell carcinoma (HNSCC) is infrequent and probably under-reported thereby leading to paucity of information. Methods: Archives of two institutes in India were studied from 2005 to 2013 and relevant information regarding patient demographics, treatment details, and follow-up was obtained for patients having brain metastasis (BM) from HNSCC. Data were analyzed using SPSS software version 20 (IBM Corporation, NY, USA). Results: Metastasis to the brain was detected in 17 patients with an HNSCC primary. The median age for diagnosis of index primary was 55 years (range (R) - 32-71 years) with 88{\%} (15/17) being male. Oral cavity was the most common site of primary disease with 35{\%} (6/17) followed by larynx (24{\%}), oropharynx (18{\%}), and hypopharynx (18{\%}). The median stage at presentation was IVA (47{\%}) and two (12{\%}) were metastatic to the brain at presentation. Human papillomavirus analysis was not available for any of the patients. Neurological symptoms were complained of in 94{\%} patients. The median BM-free-interval was 15 months (R - 1-67 months, SE ± 5.2). While 88{\%} had multiple brain metastases, 82{\%} also had extracranial metastasis and in 53{\%} of patients, the index primary was not controlled. The median overall survival of all patients after the development of BM was 2 months (R - 0.5-6 months, SE ± 0.4). Conclusion: BM in HNSCC is mostly multiple, associated with extracranial metastasis and can occur in patients without locoregional relapse or residual disease and carries a dismal outcome.",
author = "Sarbani Ghosh-Laskar and Agarwal, {Jai Prakash} and Yathiraj, {Prahlad H.} and Prasad Tanawade and Rajendra Panday and Tejpal Gupta and Ashwini Budrukkar and Vedang Murthy",
year = "2016",
month = "7",
day = "1",
doi = "10.4103/0973-1482.184525",
language = "English",
volume = "12",
pages = "1160--1163",
journal = "Journal of Cancer Research and Therapeutics",
issn = "0973-1482",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma : A case series and review of literature. / Ghosh-Laskar, Sarbani; Agarwal, Jai Prakash; Yathiraj, Prahlad H.; Tanawade, Prasad; Panday, Rajendra; Gupta, Tejpal; Budrukkar, Ashwini; Murthy, Vedang.

In: Journal of Cancer Research and Therapeutics, Vol. 12, No. 3, 01.07.2016, p. 1160-1163.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma

T2 - A case series and review of literature

AU - Ghosh-Laskar, Sarbani

AU - Agarwal, Jai Prakash

AU - Yathiraj, Prahlad H.

AU - Tanawade, Prasad

AU - Panday, Rajendra

AU - Gupta, Tejpal

AU - Budrukkar, Ashwini

AU - Murthy, Vedang

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background: Brain metastasis from primary head and neck squamous cell carcinoma (HNSCC) is infrequent and probably under-reported thereby leading to paucity of information. Methods: Archives of two institutes in India were studied from 2005 to 2013 and relevant information regarding patient demographics, treatment details, and follow-up was obtained for patients having brain metastasis (BM) from HNSCC. Data were analyzed using SPSS software version 20 (IBM Corporation, NY, USA). Results: Metastasis to the brain was detected in 17 patients with an HNSCC primary. The median age for diagnosis of index primary was 55 years (range (R) - 32-71 years) with 88% (15/17) being male. Oral cavity was the most common site of primary disease with 35% (6/17) followed by larynx (24%), oropharynx (18%), and hypopharynx (18%). The median stage at presentation was IVA (47%) and two (12%) were metastatic to the brain at presentation. Human papillomavirus analysis was not available for any of the patients. Neurological symptoms were complained of in 94% patients. The median BM-free-interval was 15 months (R - 1-67 months, SE ± 5.2). While 88% had multiple brain metastases, 82% also had extracranial metastasis and in 53% of patients, the index primary was not controlled. The median overall survival of all patients after the development of BM was 2 months (R - 0.5-6 months, SE ± 0.4). Conclusion: BM in HNSCC is mostly multiple, associated with extracranial metastasis and can occur in patients without locoregional relapse or residual disease and carries a dismal outcome.

AB - Background: Brain metastasis from primary head and neck squamous cell carcinoma (HNSCC) is infrequent and probably under-reported thereby leading to paucity of information. Methods: Archives of two institutes in India were studied from 2005 to 2013 and relevant information regarding patient demographics, treatment details, and follow-up was obtained for patients having brain metastasis (BM) from HNSCC. Data were analyzed using SPSS software version 20 (IBM Corporation, NY, USA). Results: Metastasis to the brain was detected in 17 patients with an HNSCC primary. The median age for diagnosis of index primary was 55 years (range (R) - 32-71 years) with 88% (15/17) being male. Oral cavity was the most common site of primary disease with 35% (6/17) followed by larynx (24%), oropharynx (18%), and hypopharynx (18%). The median stage at presentation was IVA (47%) and two (12%) were metastatic to the brain at presentation. Human papillomavirus analysis was not available for any of the patients. Neurological symptoms were complained of in 94% patients. The median BM-free-interval was 15 months (R - 1-67 months, SE ± 5.2). While 88% had multiple brain metastases, 82% also had extracranial metastasis and in 53% of patients, the index primary was not controlled. The median overall survival of all patients after the development of BM was 2 months (R - 0.5-6 months, SE ± 0.4). Conclusion: BM in HNSCC is mostly multiple, associated with extracranial metastasis and can occur in patients without locoregional relapse or residual disease and carries a dismal outcome.

UR - http://www.scopus.com/inward/record.url?scp=85009216301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009216301&partnerID=8YFLogxK

U2 - 10.4103/0973-1482.184525

DO - 10.4103/0973-1482.184525

M3 - Review article

C2 - 28054528

AN - SCOPUS:85009216301

VL - 12

SP - 1160

EP - 1163

JO - Journal of Cancer Research and Therapeutics

JF - Journal of Cancer Research and Therapeutics

SN - 0973-1482

IS - 3

ER -